On October 25, 2023, Lipella Pharmaceuticals Inc. closed the transaction. The company has received $2,000,000 pursuant to Regulation D and included participation from single investor.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.7282 USD | -3.55% | -2.91% | -28.61% |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-28.61% | 5.74M | |
+8.63% | 115B | |
+13.17% | 107B | |
-12.76% | 22.31B | |
-3.99% | 21.6B | |
-7.19% | 18.23B | |
-39.93% | 17.62B | |
+6.67% | 14.26B | |
+33.90% | 12.37B | |
-28.60% | 8.28B |
- Stock Market
- Equities
- LIPO Stock
- News Lipella Pharmaceuticals Inc.
- Lipella Pharmaceuticals Inc. announced that it has received $1.998685 million in funding